Scope, the roll-forward of a lagged net asset value, the statement that arrives before issuance, the disclosures, and the probable sale that ends the expedient.
When an interest in a private fund has no quoted price, ASC 820 lets the investor use the fund's net asset value as fair value, without building a model of its own. The expedient is narrow: the fund has to report like an investment company, the net asset value has to be as of the measurement date, and the expedient stops as soon as a sale below net asset value becomes probable. One fund interest followed through two year-ends shows each step.
Worked in full in The Fair Value Measurement Handbook by Julian R. Sterling, with every figure reproduced in a free workbook.Get the DRM-free PDF, $19.99 →
As read in November 2026, the practical expedient of ASC 820 applies to an investment that has no readily determinable fair value and that is in an investment company within ASC 946, or in a real estate fund that measures its investments at fair value and reports consistently with ASC 946. The investor may then estimate fair value using the net asset value per share, or its equivalent such as partners' capital, if it is calculated consistently with ASC 946 measurement principles as of the measurement date. The election is made investment by investment and applies to the whole position.
The case is fictional: Calderwick Instruments, Inc., a listed US maker of measurement instruments that reports under US GAAP with a calendar year. Every price, rate, probability and amount below is a teaching assumption of that case, not a market figure, and the facts of your own entity govern. It holds an interest in a private credit fund, a limited partnership that is an investment company, with a commitment of $10,000,000, no redemption right, and distributions that come as the fund's loans repay.
| 2025 | Amount |
|---|---|
| Capital called in 2025 | $6,500,000 |
| Distributions received in 2025 | $250,000 |
| Net asset value at 31 December 2025 | $6,710,000 |
| Gain in net income: $6,710,000 - $6,500,000 + $250,000 | $460,000 |
The fund's statement at 31 December 2025 was available for the close, so the interest is carried at $6,710,000. The gain is the change in net asset value adjusted for the cash that moved: money called increases the carrying amount without being a gain, and distributions reduce it without being a loss.
At the 2026 close the latest statement was dated 30 September 2026. A net asset value that is not as of the measurement date cannot simply be copied: the investor considers whether to adjust the latest one to estimate a net asset value consistent with ASC 946 at the measurement date. The company rolled it forward for the fourth-quarter capital activity it knew about, $8,420,000 + $500,000 - $300,000 = $8,620,000, and documented each step with its source.
On 20 February 2027, before the statements were issued, the fund's statement at 31 December 2026 arrived showing $8,655,000. It is evidence about a condition that existed at the balance sheet date, so the company recorded it: an adjustment of $35,000. The comparison between the estimate and the later statement also goes in the file, because it is the evidence of how reliable the roll-forward method has been.
| 2026 | Amount |
|---|---|
| Net asset value at 30 September 2026, latest received | $8,420,000 |
| Fourth-quarter capital called | $500,000 |
| Fourth-quarter distribution received | $300,000 |
| Rolled-forward estimate at 31 December 2026 | $8,620,000 |
| Statement at 31 December 2026, received 20 February 2027 | $8,655,000 |
| Adjustment recorded | $35,000 |
| Gain in net income 2026: $8,655,000 - $6,710,000 - $2,000,000 + $900,000 | $845,000 |
| Unfunded commitment: $10,000,000 - $6,500,000 - $2,000,000 | $1,500,000 |
Investments measured with the expedient are not categorized in Level 1, 2 or 3. Their amount is disclosed apart so that the hierarchy table reconciles to the balance sheet: $34,103,000 in the hierarchy plus $8,655,000 at net asset value gives the $42,758,000 of assets at fair value (see how the hierarchy is built). The disclosures for these investments include, by class, the fair value, the unfunded commitments, the redemption terms and frequency, notice periods and restrictions, and the timing of the investees' liquidation. Since ASU 2018-13, that timing is disclosed only when the investee has communicated it or announced it publicly; here the manager has not, and the note says so. The unfunded commitment of $1,500,000 is disclosed.
The expedient cannot be used for an investment, or the portion of it, that is probable of being sold at an amount different from net asset value at the measurement date. A sale is probable only when management with the authority has committed to a plan, an active program to find a buyer has started, the investment is available for immediate sale, and the plan is unlikely to change; the investments to be sold must be identified.
As an illustration, not an event of the case: had the company committed to sell its interest on the secondary market and a sale at 94 percent of net asset value become probable, the interest would be measured at fair value, for instance at the expected price of 94 percent x $8,655,000 = $8,135,700, and categorized in the hierarchy, in Level 3 unless the price is observable.
The SEC staff statement of 28 September 2026 on private assets, which imposes no new legal requirements, reminds auditors to apply professional skepticism to significant assumptions and to the reliability of data, including the investee statements behind a net asset value. In practice that means the file holds the statements, the fund's basis of preparation, the roll-forward with its sources, the later statement and the comparison.
IFRS 13 has no such expedient: a fund interest is measured at fair value, with net asset value as a possible starting point, and is categorized in the hierarchy.
Rules are described as read in November 2026 from the FASB Accounting Standards Codification (Topic 820, and Topics 321, 805 and 946 where named) and IFRS 13, and they change. This page is education, not accounting or audit advice: your entity's facts govern, and its accountants and auditors decide.
A permission in ASC 820 to measure an investment in an investment company, or a similar real estate fund, at its net asset value per share when the investment has no readily determinable fair value and the net asset value is calculated under ASC 946 as of the measurement date.
Not without considering an adjustment. The latest net asset value is rolled forward to the measurement date for what is known, such as capital calls and distributions, and a later statement received before issuance is recorded if it gives evidence about conditions at the balance sheet date.
No. Under ASC 820 it is not categorized in the hierarchy; its amount is shown apart so the table reconciles to the balance sheet.
When a sale of the investment, or of part of it, at an amount different from net asset value is probable at the measurement date. That portion is then measured at fair value and categorized in the hierarchy.
No. Under IFRS 13 a fund interest is measured at fair value, with net asset value as a possible starting point, and is categorized in the hierarchy.
This article is one step of The Fair Value Measurement Handbook. The book follows one listed company through two year-ends: seven instruments measured and placed in the hierarchy, a pricing service challenged, a swap that changes sides, an earn-out remeasured until its contingency is resolved, private shares re-anchored to a new round, a fund at net asset value, a plant written down on its highest and best use, and the fair value note written line by line, with IFRS 13 compared where it differs.
Paperback PDF edition, $19.99 Book page and free files
Free: the fair value hierarchy and Level 3 roll-forward model in Excel.
Case figures computed by the book's model; the companies are fictional and every term is a teaching assumption. Figures checked on 20 November 2026. Rules described as read on the dates given; not accounting or audit advice.